Quick Answer
ICU MEDICAL INC/DE reported Research And Development Expense of $87.50 million for the year ending 2025.
- ICU MEDICAL INC/DE showed a decrease of -1.3% in Research And Development Expense from 2024 to 2025.
- This data is from ICU MEDICAL INC/DE's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $1.07 million | Q1 2011: $2.05 million | Q2 2011: $2.49 million | Q3 2011: $1.88 million | Q1 2012: $2.69 million | Q2 2012: $2.73 million | Q3 2012: $2.99 million | Q1 2013: $1.90 million | Q2 2013: $3.91 million | Q3 2013: $3.14 million | Q1 2014: $3.63 million | Q2 2014: $4.57 million | Q3 2014: $5.06 million | Q1 2015: $4.31 million | Q2 2015: $3.12 million | Q3 2015: $4.23 million | Q1 2016: $3.31 million | Q2 2016: $3.34 million | Q3 2016: $3.65 million | Q1 2017: $11.64 million | Q2 2017: $12.97 million | Q3 2017: $12.77 million | Q1 2018: $12.59 million | Q2 2018: $13.58 million | Q3 2018: $13.18 million | Q1 2019: $12.82 million | Q2 2019: $11.20 million | Q3 2019: $12.00 million | Q1 2020: $10.75 million | Q2 2020: $10.28 million | Q3 2020: $10.13 million | Q1 2021: $10.71 million | Q2 2021: $11.39 million | Q3 2021: $12.24 million | Q1 2022: $23.87 million | Q2 2022: $22.56 million | Q3 2022: $23.11 million | Q1 2023: $19.76 million | Q2 2023: $22.30 million | Q3 2023: $20.87 million | Q1 2024: $21.84 million | Q2 2024: $23.39 million | Q3 2024: $21.03 million | Q1 2025: $23.29 million | Q2 2025: $21.87 million | Q3 2025: $21.25 million.
- Over the full 18 years of available data (2008 to 2025), ICU MEDICAL INC/DE's Research And Development Expense has grown by 1,714.5%.
- Historical annual values: Fiscal year 2025: $87.50 million | Fiscal year 2024: $88.62 million | Fiscal year 2023: $85.34 million | Fiscal year 2022: $92.98 million | Fiscal year 2021: $47.50 million | Fiscal year 2020: $42.95 million | Fiscal year 2019: $48.61 million | Fiscal year 2018: $52.87 million | Fiscal year 2017: $51.25 million | Fiscal year 2016: $12.96 million | Fiscal year 2015: $15.71 million | Fiscal year 2014: $18.33 million | Fiscal year 2013: $12.41 million | Fiscal year 2012: $10.63 million | Fiscal year 2011: $8.59 million | Fiscal year 2010: $4.68 million | Fiscal year 2009: $2.65 million | Fiscal year 2008: $4.82 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: